FDA Drug Application (021453) for ZERIT XR by BRISTOL MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Application Number021453
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage37.5MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZERIT XR
Active IngredientSTAVUDINE



Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.